ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

OCUL Ocular Therapeutix Inc

6,32
0,45 (7,67%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Ocular Therapeutix Inc OCUL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,45 7,67% 6,32 00:08:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,06 6,03 6,395 6,17 5,87
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.5.202413:30GLOBEOcular Therapeutix™ To Present at Two Ophthalmology..
01.5.202413:30GLOBEOcular Therapeutix™ to Host Investor Day in New York City on..
11.3.202421:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
11.3.202421:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11.3.202421:10EDGAR2Form 8-K - Current report
11.3.202411:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
27.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202402:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
27.2.202402:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
22.2.202414:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
22.2.202413:34EDGAR2Form 8-K - Current report
19.2.202415:00PRNUSAffaMed Therapeutics Announces New Drug Application..
15.2.202414:00GLOBEOcular Therapeutix™ Appoints Steve Meyers to Chief..
15.2.202401:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202413:37GLOBEOcular Therapeutix™ Announces First Subjects Screened in..
07.2.202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202422:41EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:39EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:36EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:33EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:30EDGAR2Form 144 - Report of proposed sale of securities
03.2.202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:41EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:39EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:36EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:34EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:31EDGAR2Form 144 - Report of proposed sale of securities
25.1.202414:04EDGAR2Form 8-K - Current report
28.12.202322:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22.12.202322:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18.12.202322:52EDGAR2Form SC 13D/A - General statement of acquisition of..
18.12.202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:01GLOBEOcular Therapeutix™ Announces Closing of Public Offering of..
14.12.202322:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14.12.202314:46EDGAR2Form 8-K - Current report
14.12.202304:09GLOBEOcular Therapeutix™ Announces Pricing of Public Offering of..
14.12.202301:07DJNStocks to Watch: Adobe, Amtech Systems, Ocular Therapeutix
13.12.202322:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13.12.202322:01GLOBEOcular Therapeutix™ Announces Proposed Public Offering of..
17.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness

Kürzlich von Ihnen besucht

Delayed Upgrade Clock